New Leukaemia drug approved on the NHS
Health watchdogs have done a U-turn in regards to a new cancer treatment for patients with leukaemia, enabling patients in England and Wales to have access to the drug. The drug known as Gazyvaro aims to treat those with Chronic Lymphocytic Leukaemia (CLL), and claims to have the ability to reduce risk of death by … [Read more…]